Aastrom Biosciences, Inc.

Basic Information

Domio'S Farms. Lobby L, 24 Frank Lloyd Wright Dr.
Ann Arbor, MI, 48105

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Clinical-scale Production of Osteoprogenitor Cells

    Amount: $743,066.00

    DESCRIPTION (provided by applicant): Due to morbidity and limited amounts of material, alternatives to autologous grafts for bone repair are desirable. Cells within the bone marrow are known to posses ...

    SBIR Phase II 2005 Department of Health and Human Services
  2. Clinical Human Cell Production System for Broad Use

    Amount: $798,266.00

    The therapeutic potential of patient-specific cultured cells continues to rapidly grow for a range of medical needs, such as regenerative repair of damaged tissue, cancer, and infectious diseases. As ...

    SBIR Phase II 2005 Department of Health and Human Services
  3. Dendritic Cell Subset for Enhanced Cancer Vaccine

    Amount: $109,586.00

    DESCRIPTION (provided by applicant): Tumor antigen primed dendritic cells (DCs) are under widespread clinical evaluation for immunotherapy of multiple forms of cancer. Emerging evidence suggests that ...

    SBIR Phase I 2004 Department of Health and Human Services
  4. Bioreactor for Enhanced T-cell Based Therapy of Melanoma

    Amount: $124,154.00

    DESCRIPTION (provided by applicant): Malignant melanoma is a significant and deadly form of cancer worldwide. Emerging evidence has shown that melanoma cells express tumor-associated antigens that ar ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. Clinical Human Cell Production System for Broad Use

    Amount: $101,452.00

    DESCRIPTION (provided by applicant): As a result of growing evidence of their therapeutic potential in cancer, infectious diseases, and tissue repair, there is an enormous increase in the research an ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Enhanced Tumor Antigen Priming of Dendritic Cell Vaccine

    Amount: $101,262.00

    DESCRIPTION (provided by the applicant): Dendritic cells have been shown to initiate, regulate, and direct cytolytic T-cell-mediated immune responses against tumor antigens in human patients. Recent ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. Automated Perfused Culture Process for Adult Stem Cells

    Amount: $442,555.00

    DESCRIPTION (provided by applicant): Adherent mesenchymal cell populations derived from bone marrow (BM) have the capability of differentiating into multiple cell lineages in vitro and in vivo. The po ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. Clinical-scale Production of Osteoprogenitor Cells

    Amount: $110,062.00

    DESCRIPTION (provided by applicant): Due to morbidity and limited amounts of material, alternatives to autologous grafts for bone repair are desirable. Mixtures of marrow stromal cells (MSC) and carr ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. Automated Large-Scale Production of Endothelial Cells

    Amount: $99,840.00

    DESCRIPTION (provided by applicant): Treatment of ischemia by administration of bone marrow (BM)-derived endothelial progenitor cells (EPC) or ex vivo expanded EPC populations has been shown to enhanc ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government